Background: Parry Romberg disease (hemifacial atrophy) and linear scleroderma (coup de sabre) are progressive, usually unilateral facial atrophies of unknown cause. The gold standard treatment for these patients has been microsurgical reconstruction following the "burning out" of the facial atrophy and stable contour for 2 years.

Methods: The authors report their experience treating patients with hemifacial atrophy and linear scleroderma with free tissue transfers between 1989 and 2016. A modified parascapular flap based on the circumflex scapular artery was most commonly used.

Results: A total of 177 patients were included. The most common complication was hematoma, occurring in 12 patients (7 percent). Follow-up ranged from 1 to 26 years. All patients subjectively experienced improved facial symmetry and aesthetics. No disease process has recurred to date, even in cases of severe, progressive disease.

Conclusions: In the authors' experience, patients treated early in their disease course have immediate and sustained correction of their deformity, with slowing or in most cases cessation of the disease process following free tissue transfer. The authors now advocate for immediate reconstruction for active disease, especially in young children.

Clinical Questions/level Of Evidence: Therapeutic, IV.

Download full-text PDF

Source
http://dx.doi.org/10.1097/PRS.0000000000004922DOI Listing

Publication Analysis

Top Keywords

hemifacial atrophy
12
atrophy linear
12
linear scleroderma
12
microsurgical reconstruction
8
free tissue
8
disease process
8
patients
6
disease
5
26-year experience
4
experience microsurgical
4

Similar Publications

Hemifacial spasm (HFS) is an important condition for plastic surgeons to understand, as it significantly affects patients' quality of life and can complicate aesthetic and reconstructive procedures. Magnetic resonance imaging (MRI) has become vital in diagnosing HFS, assessing neurovascular relationships, and planning treatment. Transverse MRI scans often show an upward displacement of the inferior pons at the facial nerve attachment point, signaling neurovascular compression (NVC) in HFS.

View Article and Find Full Text PDF

Progressive hemifacial atrophy (PHA) and linear scleroderma (LS) are both rare conditions and defined by atrophy and/or sclerosis of the skin and subcutaneous tissue. The ideal timing of reconstructive intervention in these patients is controversial. We compared the outcome and satisfaction of autologous lipofilling performed during active and stable phases of the diseases in adults.

View Article and Find Full Text PDF

Sturge-Weber syndrome: an overview of history, genetics, clinical manifestations, and management.

Semin Pediatr Neurol

October 2024

The University of Texas at Austin, Dell Medical School, Department of Neurology, 1601 Trinity St., Bldg. B, Stop Z0700 Austin, TX 78712, USA; Dell Children's Medical Center, 4910 Mueller Blvd Suite 300 Austin, TX 78723, USA. Electronic address:

Article Synopsis
  • * Neurological issues associated with the syndrome include epilepsy, stroke-like episodes, and cognitive impairment, with MRI typically showing characteristic brain changes.
  • * Treatment options involve surgery for glaucoma and laser therapy for port-wine stains, along with potential benefits from anti-seizure medications and low-dose aspirin for managing symptoms.
View Article and Find Full Text PDF

Parry Romberg syndrome (PRS) is a rare self-limiting disease, typically occurring in children and young adults, that causes slow progressive atrophy of one-half of the face. It primarily affects the subcutaneous tissue and skin with some cases exhibiting deeper extension to glandular, osseous and muscular structures. Neurologic and ocular involvement is variable.

View Article and Find Full Text PDF

Parry-Romberg syndrome (PRS), also recognized as progressive hemifacial atrophy (PHA), is a rare medical condition affecting the dermis, subcutaneous tissue, and occasionally underlying anatomical structures such as muscles and bones. While the etiology of this condition remains incompletely elucidated, it has been hypothesized that trauma, autoimmunity, infection, and autonomic dysregulation may constitute potential contributory factors. Typically, the onset of symptoms occurs within the initial two decades of life, though instances of late-onset PRS manifesting in the sixth and seventh decades of life have also been documented.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!